Recurrent sinonasal teratocarcinosarcoma treated with IMRT: a case report

Rajanigandha Tudu, Anup Kumar, Rashmi Singh, Payal Raina, Praveer Kumar Singh Munda


Sinonasal teratocarcinosarcoma is a rare malignant tumour displaying aggressive growth .It is known to have poor prognosis with locoregional recurrence. So far, the most widely accepted therapeutic plan for its management has been surgery followed by adjuvant radiation. This study reports a case of 35 year old male diagnosed with sinonasal undifferentiated carcinoma who presented with neck node recurrence after 15 months of definitive radiotherapy. A 35 year old patient presented with nasal obstruction and epistaxis. CECT PNS revealed mass in ethmoid sinus with adjacent bony destruction and infiltration into maxillary sinus and nasal cavity. Biopsy revealed poorly differentiated carcinoma. Patient underwent neoadjuvant chemotherapy followed by definitive radiotherapy by IMRT. On follow up at 15 months, the patient presented with nodal recurrence. Biopsy from neck node revealed metastatic sinonasal teratocarcinosarcoma. The patient underwent neck dissection followed by adjuvant chemoradiation. The patient is currently on follow up and is disease free till date. Surgery alongwith adjuvant chemoradiation is a reasonable therapeutic approach of management for sinonasal teratocarcinosarcoma.



Sinonasal carcinoma, Teratocarcinosarcoma, IMRT

Full Text:



Shanmugaratnam K, Kunaratnam N, Chia KB, Chiang GS, Sinniah R. Teratoid carcinosarcoma of the paranasal sinuses. Pathology. 1983;15(4):413-9.

Heffner DK, Hyams VJ. Teratocarcinosarcoma (malignant teratoma?) of the nasal cavity and paranasal sinuses. A clinicopathologic study of 20 cases. Cancer. 1984;53:2140-54.

Chakraborty S, Chowdhury AR, Bandyopadhyay G. Sinonasal teratocarcinosarcoma: case report of an unusual neoplasm. J Oral Maxillofac Pathol. 2016;20(1):147-50.

Charlotte BL, Roel SJHM, Jean B, Wilfried B, Cai G, Vincent G, et al. CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. Radiotherapy and Oncology. 2015;117(1):83-90.

Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S10-9.

Terasaka S, Medary MB, Whiting DM, Fukushima T, Espejo EJ, Nathan G. Prologed survival in a patient with sinonasal teratocarcinosarcoma with cranial extension: case report. J Neurosurg. 1998;88(4):753-56.

Batsakis JG, El-Naggar AK, Luna MA. Teratomas of the head and neck with emphasis on malignancy. Ann Otol Rhinol Laryngol. 1995;104(6):496-500.

Pai SA, Naresh KN, Masih K, Ramarao C, Borges AM. Teratocarcinosarcoma of the paranasal sinuses: a clinicopathologic and immunohistochemical study. Human Pathology. 1998;29(7):718-722.

Budrukkar A, Agarwal JP, Kane S. Management and clinical outcome of sinonasal teratocarcinosarcoma: single institution experience. J Laryngol Otol. 2010;124(7):739-43.

Daly ME, Chen AM, Bucci MK, El-Sayed I, Xia P, Kaplan MJ, et al. Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys. 2007;67(1):151-7.

Duthoy W, Boterberg T, Claus F, Ost P, Vakaet L, Bral S, et al. Postoperative intensity modulated radiotherapy in sinonasal carcinoma: clinical results in 39 patients. Cancer. 2005;104(1):71-82.

Madani I, Bonte K, Vakaet L, Boterberg T, De Neve W. Intensity modulated radiotherapy for sinonasal tumors: Ghent University Hospital update. Int J Radiat Oncol Biol Phys. 2009;73(2):424-32.

Vranic S, Caughron S, Djuricic S, Bilalovic N, Zaman S, Suljevic I, et al. Hamartomas, teratomas and teratocarcinosarcomas of the head and neck: report of 3 new cases with clinico-pathologic correlation, cytogenetic analysis, and review of the literature. BMC Ear, Nose and Throat Disorders. 2008;8:8.